0.1940
27-十二月-24 15:45:00
15 分钟延时
股票
+0.0101
+5.49%
今日范围
0.1810 - 0.2050
ISIN
N/A
来源
NASDAQ
Vincerx Pharma Publishes Preclinical Data Demonstrating Therapeutic Potential of Small Molecule-Drug Conjugate VIP236 in the Journal Cancers
03 2月 2022 07:30:00 条件 Nasdaq GlobeNewswire
Vincerx Pharma Announces First Patient Dosed in Phase 1 Dose-Escalation Study of VIP152 in Relapsed or Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
17 12月 2021 07:00:00 条件 Nasdaq GlobeNewswire
Vincerx Pharma Presents Data on PTEFb/CDK9 Inhibitor VIP152 in DLBCL and CLL at the 63rd American Society of Hematology Annual Meeting
11 12月 2021 14:30:00 条件 Nasdaq GlobeNewswire
Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma
07 12月 2021 07:00:01 条件 Nasdaq GlobeNewswire